{"id":47,"date":"2024-02-18T09:58:02","date_gmt":"2024-02-18T09:58:02","guid":{"rendered":"http:\/\/192.168.82.35\/wordpress\/?page_id=47"},"modified":"2024-04-25T13:58:12","modified_gmt":"2024-04-25T12:58:12","slug":"the-epad-story","status":"publish","type":"page","link":"https:\/\/ep-ad.org\/index.php\/the-epad-story\/","title":{"rendered":"The EPAD story"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-text-align-center\">Making the most of a window of opportunity.<\/h2>\n\n\n\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-12243e0f wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group is-content-justification-space-between is-nowrap is-layout-flex wp-container-core-group-is-layout-cb46ffcb wp-block-group-is-layout-flex\">\n<p class=\"wp-container-content-9cfa9a5a\">There\u2019s compelling evidence that Alzheimer\u2019s disease takes hold in the brain decades before dementia symptoms appear, providing a window of opportunity for preventat intervention.<br><br>The European Prevention of Alzheimer\u2019s Dementia (EPAD) consortium was driven by the idea that early, targeted intervention focused on the initial stages of disease would be more effective than efforts to tackle established disease processes.<\/p>\n\n\n\n<p class=\"wp-container-content-9cfa9a5a\">With gratitude to the Innovative Medicines Initiative (IMI) for funding (2015-2020), EPAD was an interdisciplinary research initiative established to overcome the major hurdles hampering drug development for secondary prevention of dementia due to Alzheimer\u2019s disease. It also pioneered a novel, flexible approach to clinical trials.<br><br>Additional thanks to Fidelity Bermuda Foundation and Alzheimer\u2019s Association for their support of the EPAD Bioresource.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Making the most of a window of opportunity. There\u2019s compelling evidence that Alzheimer\u2019s disease takes hold in the brain decades before dementia symptoms appear, providing a window of opportunity for preventat intervention. The European Prevention of Alzheimer\u2019s Dementia (EPAD) consortium was driven by the idea that early, targeted intervention focused on the initial stages of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-47","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/47","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=47"}],"version-history":[{"count":3,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/47\/revisions"}],"predecessor-version":[{"id":9980,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/47\/revisions\/9980"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=47"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}